Kamizono et al “Susceptible locus for obese type II diabetes mellitus in the 5′ flanking region of the tumor necrosis factor-alpha-gene” Tissue Antigens, vol. 55, p. 449-452, May 2000.* |
Seki et al “Polymorphisms in the 5′-flanking region of tumor necrosis factor-alpha-gene in patients with rheumatoid arthritis” Tissue Antigens, vol. 54, p. 194-197, Aug. 1999.* |
Higuchi et al “Polymorhpism of the 5′ flanking region of the human tumor necrosis factor (TNF)-alpha-gene in Japanese” Tissue Antigens, vol. 51, pp. 605-612, Jun. 1998.* |
Deng et al “No primary association between the 308 polymorphism in the tumor necrosis factor alpha promoter region and IDDM” Human Immunology, vol. 45, p. 137-142, Feb. 1996.* |
Huizinga et al “Disease susceptibility related to the -238 TNF alpha G to A promoter polymorphism” European Cytokine Network, vol. 7, No. 2, pp. 259, 1996.* |
Shogo Takashiba et al., “Cloning and characterization of human TNFα promoter region.”, Gene, vol. 131, pp. 307-308, 1993. |
J. Vinasco et al., “Polymorphism at the TNF loci in rheumatoid arthritis.”, Tissue Antigens, vol. 49, pp. 74-78, 1997. |
C.P. Day et al., “Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance.”, Diabetologia, vol. 41, pp. 430-434, 1998. |
H. Rothe et al., “Abnormal TNF production in prediabetic BB rats is linked to defective CD45R exxpression.”, Immunology, vol. 77, pp. 1-6, 1992. |
Takafumi Higuti et al., “Relationship between polymorphism of TNF-alpha gene promoter region and ability to produce TNF-alpha .”, Presentation, Japan Immunology Society, Pacifico Yokohama Meeting Center, Nov. 27, 1996, 19 pages, Certification, 2 pages. |